Search Results - "De Robertis̄, Francesca"
-
1
Bioenergetics profile of CD4+ T cells in relapsing remitting multiple sclerosis subjects
Published in Journal of biotechnology (20-05-2015)“…Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the central nervous system. There are four clinical forms of MS, the most…”
Get full text
Journal Article -
2
A Case Report of Double Filtration Plasmapheresis in an Acute Episode of Multiple Sclerosis
Published in Therapeutic apheresis and dialysis (01-06-2008)“…: Plasma exchange has been proposed as support therapy in both acute and chronic forms of multiple sclerosis (MS). For the first time, we aimed to assess…”
Get full text
Journal Article -
3
Age-related disability in multiple sclerosis
Published in Annals of neurology (01-04-2002)“…There is evidence that the clinical course of multiple sclerosis is age related. The present study evaluated the relationship between age and rate of…”
Get full text
Journal Article -
4
Multiple Sclerosis Progression and Relapse Activity in Children
Published in JAMA neurology (01-01-2024)“…Although up to 20% of patients with multiple sclerosis (MS) experience onset before 18 years of age, it has been suggested that people with pediatric-onset MS…”
Get more information
Journal Article -
5
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
Published in Neurotherapeutics (01-07-2024)“…Treatment options for secondary progressive MS (SPMS) are limited, especially considering that the new drugs recently approved are licensed for actively…”
Get full text
Journal Article -
6
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study
Published in Journal of neurology (01-02-2022)“…Background Natalizumab (NTZ) is an effective treatment for relapsing–remitting multiple sclerosis (RRMS). However, patients and physicians may consider…”
Get full text
Journal Article -
7
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study
Published in Expert opinion on drug delivery (02-07-2016)“…The BRIDGE study has previously shown a high short-term (12 weeks) adherence rate (>85%) of patients with relapsing-remitting multiple sclerosis (RRMS) to…”
Get more information
Journal Article -
8
Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis
Published in Psychotherapy and psychosomatics (01-01-2016)Get more information
Journal Article -
9
Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
Published in BBA clinical (01-12-2016)“…Glatiramer acetate (GA; Copaxone) is a random copolymer of glutamic acid, lysine, alanine, and tyrosine used for the treatment of patients with multiple…”
Get full text
Journal Article -
10
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
Published in Journal of neurology (01-12-2019)“…Background The increase in disease-modifying drugs (DMDs) allows individualization of treatment in relapsing multiple sclerosis (RMS); however, the long-term…”
Get full text
Journal Article -
11
A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis
Published in BMC neuroscience (24-07-2015)“…Lipids play different important roles in central nervous system so that dysregulation of lipid pathways has been implicated in a growing number of…”
Get full text
Journal Article -
12
Metabolic phenotype of CD4+ T cells in Multiple Sclerosis subjects
Published in Journal of biotechnology (01-09-2014)Get full text
Journal Article -
13
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study
Published in Medical devices (Auckland, N.Z.) (01-01-2013)“…The ExtaviJect® 30G autoinjector was developed to facilitate parenteral self-administration of interferon beta-1b (Extavia®), a first-line disease-modifying…”
Get full text
Journal Article -
14
Gene symbol: NOTCH3. Disease: CADASIL
Published in Human genetics (01-06-2008)Get full text
Journal Article -
15
Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy
Published in Multiple sclerosis (01-10-2003)“…This independent, population-based surveillance study monitored the efficacy and safety of interferon beta (IFNb) products in 1033 patients with relapsing…”
Get full text
Journal Article -
16
A Case Report of Double Filtration Plasmapheresis in an Acute Episode of Multiple Sclerosis
Published in Therapeutic Apheresis and Dialysis (01-06-2008)Get full text
Report